{
  "columnHierarchy": {
    "epochs": [
      {
        "id": "epoch_1",
        "name": "Screening",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "27b713b6-b417-4e66-ab2b-94d4b5ec637b",
          "code": "C98779",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_2",
        "name": "Randomization / Start of IMP",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "2ba93a1a-3cdb-4b8f-9069-89d6660284e7",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_3",
        "name": "Year 1 (M12)",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "c11af073-cdd5-465f-aee0-d82c261f0588",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_4",
        "name": "From M15 to EOS",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "27574273-1c58-4a1f-bcce-eb866459e683",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_5",
        "name": "Only for participants who prematurely discontinue IMP",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "6f708b1a-4e21-474b-8304-df0eadeeef3d",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_6",
        "name": "For all participants",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "4c67b5df-c6c1-4526-ad3f-1412047c727a",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_7",
        "name": "Only for participants who completed treatment to EOS but do not enter LTS",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "1107030c-ae0e-431d-9f9f-6f7fccbc295d",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      }
    ],
    "encounters": [
      {
        "id": "enc_1",
        "name": "Screening (D-28 to D-1)",
        "instanceType": "Encounter",
        "type": {
          "id": "b0239b26-91a9-4ca3-b38f-ac528b85c6a9",
          "code": "C48262",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "epochId": "epoch_1"
      },
      {
        "id": "enc_2",
        "name": "Day 1",
        "instanceType": "Encounter",
        "type": {
          "id": "0c25e155-d853-4646-8759-20d055a181e9",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      },
      {
        "id": "enc_3",
        "name": "M0.5 (W2) M0.75 (W3)",
        "instanceType": "Encounter",
        "type": {
          "id": "c6c08ce6-795f-4849-a4fc-c328af9bd617",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_4",
        "name": "M1 (W4)",
        "instanceType": "Encounter",
        "type": {
          "id": "e73b5d17-28f5-48cc-a790-2c3e139cb9b9",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_5",
        "name": "M1.25 (W5) M1.5 (W6) M1.75 (W7)",
        "instanceType": "Encounter",
        "type": {
          "id": "19c6beec-5083-49eb-a4b0-00863ad185f2",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_6",
        "name": "M2 (W8)",
        "instanceType": "Encounter",
        "type": {
          "id": "8179660a-11fd-4fb1-947a-7e4152a9e708",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_7",
        "name": "M2.25 (W9) M2.5 (W10) M2.75 (W11)",
        "instanceType": "Encounter",
        "type": {
          "id": "0499fe57-0394-42c0-afc6-7bb83f9a8398",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_8",
        "name": "M3",
        "instanceType": "Encounter",
        "type": {
          "id": "8012adee-e8cd-463e-962a-8f6bc1ab59ea",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_9",
        "name": "M4, M5",
        "instanceType": "Encounter",
        "type": {
          "id": "f40dd879-7266-4122-b984-38c0c2c7eccb",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_10",
        "name": "M6",
        "instanceType": "Encounter",
        "type": {
          "id": "a1b61d1b-e0a9-4a5e-b846-6a65e57e9c3d",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_11",
        "name": "M7, M8",
        "instanceType": "Encounter",
        "type": {
          "id": "7938f16b-aa53-410f-ae90-cb8a4f0976e2",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_12",
        "name": "M9",
        "instanceType": "Encounter",
        "type": {
          "id": "939412ee-11f1-41b3-a72a-14b7838e8033",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_13",
        "name": "M10, M11",
        "instanceType": "Encounter",
        "type": {
          "id": "b4f14662-b72d-46d0-9237-fc1953ea68cf",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_14",
        "name": "M12",
        "instanceType": "Encounter",
        "type": {
          "id": "5569fb35-105a-438c-9958-73ffdadd9462",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_15",
        "name": "Quarterly visits (M15 to M36...)",
        "instanceType": "Encounter",
        "type": {
          "id": "aa5557ce-f948-4f76-9166-131e32112798",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_4"
      },
      {
        "id": "enc_16",
        "name": "Semi-annual visits (M18 to M36...)",
        "instanceType": "Encounter",
        "type": {
          "id": "b751e1b8-1ef4-4f5d-a8f2-1ecdc6502c13",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_4"
      },
      {
        "id": "enc_17",
        "name": "pEOT",
        "instanceType": "Encounter",
        "type": {
          "id": "942ee879-87c1-42b1-8cad-ab025fe03395",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_5"
      },
      {
        "id": "enc_18",
        "name": "EOS Common study end date visit",
        "instanceType": "Encounter",
        "type": {
          "id": "11cb0896-26fd-459f-8f57-4576144b2b50",
          "code": "C126070",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "End of Study",
          "instanceType": "Code"
        },
        "epochId": "epoch_6"
      },
      {
        "id": "enc_19",
        "name": "Follow-up visit (4 weeks)",
        "instanceType": "Encounter",
        "type": {
          "id": "529036fc-ac71-4b8a-952b-fb2d527a612e",
          "code": "C99158",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Follow-up",
          "instanceType": "Code"
        },
        "epochId": "epoch_7"
      }
    ],
    "plannedTimepoints": [
      {
        "id": "pt_1",
        "visit": "D-28 to D-1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_1",
        "instanceType": "Timing"
      },
      {
        "id": "pt_2",
        "visit": "D1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_2",
        "instanceType": "Timing"
      },
      {
        "id": "pt_3",
        "visit": "W2, W3",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_3",
        "instanceType": "Timing"
      },
      {
        "id": "pt_4",
        "visit": "W4",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_4",
        "instanceType": "Timing"
      },
      {
        "id": "pt_5",
        "visit": "W5, W6, W7",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_5",
        "instanceType": "Timing"
      },
      {
        "id": "pt_6",
        "visit": "W8",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_6",
        "instanceType": "Timing"
      },
      {
        "id": "pt_7",
        "visit": "W9, W10, W11",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_7",
        "instanceType": "Timing"
      },
      {
        "id": "pt_8",
        "visit": "M3",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_8",
        "instanceType": "Timing"
      },
      {
        "id": "pt_9",
        "visit": "M4, M5",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_9",
        "instanceType": "Timing"
      },
      {
        "id": "pt_10",
        "visit": "M6",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_10",
        "instanceType": "Timing"
      },
      {
        "id": "pt_11",
        "visit": "M7, M8",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_11",
        "instanceType": "Timing"
      },
      {
        "id": "pt_12",
        "visit": "M9",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_12",
        "instanceType": "Timing"
      },
      {
        "id": "pt_13",
        "visit": "M10, M11",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_13",
        "instanceType": "Timing"
      },
      {
        "id": "pt_14",
        "visit": "M12",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_14",
        "instanceType": "Timing"
      },
      {
        "id": "pt_15",
        "visit": "M15, M18, M21, M24, M27, M30, M33, M36...",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_15",
        "instanceType": "Timing"
      },
      {
        "id": "pt_16",
        "visit": "M18, M24, M30, M36...",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_16",
        "instanceType": "Timing"
      },
      {
        "id": "pt_17",
        "visit": "pEOT",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_17",
        "instanceType": "Timing"
      },
      {
        "id": "pt_18",
        "visit": "EOS",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_18",
        "instanceType": "Timing"
      },
      {
        "id": "pt_19",
        "visit": "FUV",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_19",
        "instanceType": "Timing"
      }
    ]
  },
  "rowGroups": [
    {
      "id": "grp_1",
      "name": "Pharmacogenetics",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "DNA sample"
      ]
    },
    {
      "id": "grp_2",
      "name": "Pharmacodynamics/biomarkers",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Blood sample for archiving",
        "Plasma samples (NfL), serum samples (Chi3L1)",
        "Serum samples (Ig levels)"
      ]
    }
  ],
  "footnotes": [
    "a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1 week (7 days) is allowed.",
    "b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.",
    "c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.",
    "d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.",
    "e If a participant prematurely permanently discontinues treatment with IMP, the participant will undergo a premature EOT visit as soon as possible. Participants will then be asked to continue with the study visits as scheduled, until global EOS visit is reached. During these visits, all study procedures/assessments will be performed except IMP administration and blood sampling for biomarkers (NfL, Chi3L1, and Ig levels). MRI scans for these participants will only be performed annually (using the next annual visit as the starting point).",
    "f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.",
    "g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.",
    "h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.",
    "i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examination is sufficient for the rest of the visits (complete and brief physical examination will include neurological examination and collection of the following vital signs: arterial blood pressure, heart rate, and temperature).",
    "j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).",
    "k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, reticulocytes, white blood cell count with differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils). Biochemistry (blood urea nitrogen [BUN], creatinine, glucose, potassium, sodium, chloride, bicarbonate, calcium; liver function tests [AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein; creatine phosphokinase], lipase at Screening Visit, then quarterly). Monthly visits (M1, M2, M4, M5) will include hematology and full liver panel only. Additional safety assessments can be performed if required by local regulations. Such testing shall be performed at local laboratories. Note: a one-time retest at screening may be performed if an abnormal laboratory test value is considered temporary. Additional visits may be added if required by local regulations.",
    "l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.",
    "m Serum β-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 hours before the first dose of IMP and at scheduled times during study. Additional serum or urine pregnancy tests may be performed, as determined necessary by the Investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. Communication by phone of the result of a pregnancy test performed at home to the site is allowed. See also Appendix 4 (Section 10.4).",
    "n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).",
    "o Only in female participants, if needed to establish menopausal status.",
    "p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.",
    "q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of ±21 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the screening period after it has been established that the participant meets all inclusion and no exclusion criteria.",
    "r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.",
    "s Where available per local regulations.",
    "t Pharmacodynamics/biomarkers samples collected are not timed samples.",
    "u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).",
    "v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure that a pre-dose baseline value is available for previously not assessed parameters (eg, serology) and for biomarkers research, if agreed.",
    "w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to administration of the first IMP dose."
  ]
}